Recognizing And Treating Lower Extremity Gout
- Volume 25 - Issue 2 - February 2012
- 16756 reads
- 0 comments
With the onset of the baby boomers getting older, the further scope of podiatric medicine integrated with the changes in the healthcare system of more comprehensive, collaborative, correlated care, podiatrists must be well educated on the options for the acute management and chronic treatment of hyperuricemia. It is crucial to rule out sepsis because symptoms of acute gout can mimic an infectious process.
The patient population must have the knowledge of all phases of the disease in order to manage their hyperuricemia and gout effectively. Typically, physicians must manage the intercritical phase well in order to decrease the incidence of acute attacks and limit the further risk of joint destruction.
By treating the underlying epidemic of metabolic syndrome and other disease states in concert with other members of the healthcare team, we will hopefully see a decreased prevalence of gout. Along with multidisciplinary collaboration, we will hopefully see more patient education on how to minimize known risk factors and prevent hyperuricemia.
Dr. Romansky is a Fellow of the American College of Foot and Ankle Surgeons. He is in private practice at Healthmark Foot and Ankle Associates in Media and Phoenixville, Pa.